Particularly in RA-ILD+ patients, MMP-9, TIMP-1, and TIMP-2 were also decreased compared to the levels of these molecules in patients with IPF (p = 0.0043, p = 0.0043 and p = 0.0431, respectively, Fig. 2A). This evidence concerns the gene TIMP1 and rheumatoid arthritis.